Carillon Tower Advisers’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $6.87M | Sell |
196,772
-16,236
| -8% | -$567K | 0.04% | 372 |
|
|
2020
Q3 | $7.4M | Sell |
213,008
-17,440
| -8% | -$605K | 0.1% | 291 |
|
|
2020
Q2 | $7.55M | Sell |
230,448
-116,682
| -34% | -$3.82M | 0.06% | 327 |
|
|
2020
Q1 | $10.4M | Sell |
347,130
-40,230
| -10% | -$1.21M | 0.1% | 265 |
|
|
2019
Q4 | $11.2M | Sell |
387,360
-15,050
| -4% | -$436K | 0.07% | 316 |
|
|
2019
Q3 | $10.4M | Sell |
402,410
-48,324
| -11% | -$1.25M | 0.07% | 327 |
|
|
2019
Q2 | $11.5M | Sell |
450,734
-16,888
| -4% | -$431K | 0.08% | 324 |
|
|
2019
Q1 | $12.2M | Sell |
467,622
-25,406
| -5% | -$665K | 0.09% | 306 |
|
|
2018
Q4 | $11.4M | Sell |
493,028
-93,990
| -16% | -$2.17M | 0.1% | 289 |
|
|
2018
Q3 | $13.8M | Sell |
587,018
-63,756
| -10% | -$1.5M | 0.1% | 291 |
|
|
2018
Q2 | $15M | Buy |
650,774
+33,756
| +5% | +$778K | 0.12% | 260 |
|
|
2018
Q1 | $15.2M | Buy |
+617,018
| New | +$15.2M | 0.12% | 240 |
|